Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Zalina T. Fidarova"'
Autor:
Elena N. Parovichnikova, Irina A. Lukianova, Vera V. Troitskaya, Mikhail Yu. Drokov, Larisa A. Kuzmina, Andrei N. Sokolov, Alina V. Kokhno, Zalina T. Fidarova, Irina V. Galtseva, Yuliya O. Davydova, Anastasiia I. Kashlakova, Elena O. Gribanova, Eugene E. Zvonkov, Elena P. Sysoeva, Valentina N. Dvirnyk, Tatiana N. Obukhova, Andrei B. Sudarikov, Yuliya V. Sidorova, Sergei M. Kulikov, Yuliia A. Chabaeva, Valerii G. Savchenko
Publikováno v:
Терапевтический архив, Vol 93, Iss 7, Pp 753-762 (2021)
Aim. To analyze the results of treatment in patients with acute myeloid leukemia (AML) within protocols AML-17 and modified AML-17 (mOML-17) as part of two consecutive pilot studies in order to develop the best treatment strategy for AML patients age
Externí odkaz:
https://doaj.org/article/ead7e57f92e747e7b74baee842d7e924
Autor:
Anton V. Luchkin, Elena A. Mikhailova, Zalina T. Fidarova, Vera V. Troitskaya, Irina V. Galtseva, Alla M. Kovrigina, Svetlana A. Glinkina, Valentina N. Dvirnyk, Elena V. Raykina, Anna V. Pavlova, Irina A. Demina, Elena N. Parovichnikova
Publikováno v:
Терапевтический архив, Vol 93, Iss 7, Pp 818-825 (2021)
Dyskeratosis congenita (DC) is a hereditary syndrome of bone marrow failure, which develops because of telomeres defects and combines with cancer predisposition. Its classical clinical features are skin pigmentation, nail dystrophy, oral leukoplakia
Externí odkaz:
https://doaj.org/article/b0b3e77cb25f4754b6351e21b015b70c
Autor:
Yu A Kondratieva, S V Subbotin, L P Mendeleeva, E A Mikhailova, Irina V. Galtseva, K A Nikiforova, T V Gaponova, Maxim L. Filipenko, Yu. O. Davydova, E A Khrapov, Anton V. Luchkin, Elena N. Parovichnikova, V G Savchenko, Zalina T. Fidarova, Nikolay M. Kapranov
Publikováno v:
Russian Clinical Laboratory Diagnostics. 66:154-159
Telomere length can be measured by polymerase chain reaction (PCR), allowing to obtain the absolute length of telomeres (ALT) in base pair, and by flow cytometry, which can only estimate the relative telomere length. The aim of the study was to compa
Autor:
Elena Lukina, Svetlana A. Glinkina, T N Obukhova, Ksenia Nikiforova, Valeriy G. Savchenko, Elena N. Parovichnikova, Irina V. Galtseva, Nina Tsvetaeva, E A Mikhailova, Nikolay M. Kapranov, Moiseeva Tn, A V Kokhno, V N Dvirnyk, Larisa A. Kuzmina, Vera V. Troitskaya, Zalina T. Fidarova, Yulia Davydova, Olga F. Nikulina, Alla M. Kovrigina
Publikováno v:
Cytometry Part B: Clinical Cytometry. 100:312-321
Background Myelodysplastic syndromes (MDS) can present a challenge for clinicians. Multicolor flow cytometry (MFC) can aid in establishing a diagnosis. The aim of this study was to determine the optimal MFC approach for MDS. Methods The study include
Autor:
E. A. Mikhaylova, Yu. А. Chabaeva, Sergei M. Kulikov, Irina V. Galtseva, Elena N. Parovichnikova, Zalina T. Fidarova, A. V. Abramova, V N Dvirnyk, T N Obukhova, V G Savchenko, Vera V. Troitskaya, Kliasova Ga, Alla M. Kovrigina, Anton V. Luchkin
Publikováno v:
Терапевтический архив, Vol 92, Iss 7, Pp 4-9 (2020)
Treatment programs for patients with acquired aplastic anemia include two main therapeutic options: allogeneic bone marrow transplantation and combined immunosuppressive therapy (IST). However, combined IST remains the method of choice for most adult
Autor:
Elena O. Gribanova, G M Galstyan, Sergei M. Kulikov, A V Bazhenov, Zalina T. Fidarova, U A Chabaeva, Vera V. Troitskaya, Elena N. Parovichnikova, O A Latyshkevich, S A Makhinya, Larisa A. Kuzmina, Valery G. Savchenko
Publikováno v:
Терапевтический архив, Vol 91, Iss 7, Pp 14-24 (2019)
Remission induction can be associate, with the life threatening complications and transfer to ICU of de novo acute myeloid leukemia (AML) patients (pts). We evaluate influence of transfer to ICU and life threatening complication on early mortality an
Autor:
Alexey Anikin, E P Sysoeva, Oleg Mil'ko, Eugine Zvonkov, Vera V. Troitskaya, Olga Sivakova, Anton V. Luchkin, Elena N. Parovichnikova, Olga A. Gavrilina, T V Gaponova, Hunan Julhakyan, Zalina T. Fidarova, Karen Danishyan, Tikhomirov Ds, Tatyana Tupoleva, Elena O. Gribanova, Grigoriy Efimov, Yana Mangasarova, Sergey Boitsov, Valeriy G. Savchenko, Gennadiy M. Galstyan
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia
Clinical Lymphoma, Myeloma & Leukemia
Clinical Lymphoma, Myeloma & Leukemia
Background: By 11/03/2020, the WHO had declared the COVID-19 outbreak a pandemic. At 25/05/2020 Russia ranked third by the incidence of COVID-19 and the number of confirmed cases was 344,481 with 3,541(1%) deaths. Aim: To describe the epidemiological
Autor:
Irina V. Galtseva, T N Obukhova, S A Kuznetsova, Larisa A. Kuzmina, A N Sokolov, V A Vasilyeva, J O Davidiva, Elena N. Parovichnikova, Valery G. Savchenko, Olga A. Gavrilina, Vera V. Troitskaya, I A Loukianova, Sergei M. Kulikov, Zalina T. Fidarova, Andrey Sudarikov, Mikhail Yu. Drokov, V.N. Dvirnik, T I Lobaova, A V Kokhno, G A Baskhaeva
Publikováno v:
Терапевтический архив, Vol 90, Iss 7, Pp 14-22 (2018)
Objective. To analyze treatment results of 172 patients with acute myeloid leukemia (AML) aged 18-60 years in National Medical Research Center for Hematology of MHRF. Materials and methods. Inductive and consolidation program for 139 (80%) patients w
Autor:
Anton V. Luchkin, Nina J. Drize, Zalina T. Fidarova, Irina N. Shipounova, Alena I. Dorofeeva, Elena A. Mikhaylova
Publikováno v:
Blood. 138:1131-1131
Aplastic anemia (AA) is believed to be an autoimmune disorder characterized by the pancytopenia due to the depletion of hematopoietic stem and progenitor cells in the bone marrow. There are three forms of AA depending on the severity of pancytopenia:
Autor:
Andrey N. Sokolov, Tatiana I. Lobanova, Gennadiy M. Galstyan, Sergei M. Kulikov, Sergey K. Kravchenko, Zalina T. Fidarova, Julia Chabaeva, Vera V. Troitskaya, Olga A. Gavrilina, Elena O. Gribanova, Elena N. Parovichnikova, Valeriy G. Savchenko, A V Kokhno
Publikováno v:
Blood. 134:5136-5136
Background Acute myeloid leukemia (AML) in older adults is a biologically and clinically distinct entity. These patients often have comorbidities, and their treatment must be chosen with caution. In AML patients over 60y old, cure rates are under 10%